Diversifying Excellence: Jubilant PharmaNova Expands into Nutraceuticals to Complement Cardiovascular Expertise
Context:
Jubilant PharmaNova, renowned in the cardiovascular sector, sought to augment its portfolio by introducing nutraceuticals that complement its core strengths.
NutrifyGenie AI Solution:
Ingredient Analysis: Conducted an extensive review of commonly used ingredients and various bioactives impacting cardiovascular health.
Optimization: Identified a unique blend, including an ingredient typically associated with women’s health but also beneficial for cardiovascular systems.
Operational Execution:
Research: Supported the blend choice with comprehensive clinical research.
Innovative Formulation:
- Identified ‘Quatrefolic’ – a specialized folate form, proven to lower homocysteine levels, thereby reducing plaque formation risks and kidney strain.
- Combined this with a blend of omega 3, 6, 7, and 9, underpinned by clinical evidence for a holistic cardiovascular health solution.
Outcome:
Product Launch: Successfully launched ‘Multi Omega’, now a top-performing brand in Jubilant PharmaNova’s portfolio, exemplifying strategic innovation and market alignment.
Conclusion:
Jubilant PharmaNova’s strategic foray into nutraceuticals marked a pivotal moment in its renowned legacy within the cardiovascular sector. Leveraging the NutrifyGenie AI solution, the company undertook a meticulous process.